• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Risk-based computed tomography screening for lung cancer may be superior to current screening guidelines

byJeffrey CohenandMichael Milligan
May 18, 2016
in Chronic Disease, Imaging and Intervention, Oncology, Pulmonology
Reading Time: 3 mins read
Smoking during pregnancy associated with aerobic fitness of children
Share on FacebookShare on Twitter

1. This study predicted that a risk-based, computed tomography (CT) screening program for lung cancer in individuals between 50 and 80 years of age would prevent more deaths than current United States Preventative Services Task Force (USPSTF) guidelines.

2. This risk-based screening methodology would yield a lower number needed to screen than current USPSTF guidelines.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Recent research has shown that screening with low-dose CT scans can decrease lung cancer deaths among all individuals with a history of tobacco use. Less is known, however, about the impact of CT screening based on individualized risk factors. This study utilized three cohort studies to explore the effects of conducting CT screening for lung cancer in a risk based fashion. Based on the current USPSTF guidelines, roughly 9 million people between the ages of 50 and 80 should be screened for lung cancer, which is estimated to prevent 46,488 deaths over the next 5 years. However, the results of this study concluded that screening individuals between the ages of 50 and 80 at the highest individualized risk of developing lung cancer could prevent a larger number of deaths, 55,717, over the next 5 years.

The risk-based model utilizes a specific patient’s demographics and social history to calculate their expected 5-year risk of developing lung cancer, and recommends CT screening only for those at the highest risk. Based on this study’s modeling, screening an equal number of patients based on their individualized risk would be superior to the current USPSTF guidelines. While this study is strengthened by its large sample sizes and detailed individual data, it is limited by the use of models to estimate outcomes. Therefore, a randomized controlled trial applying this risk-based methodology against the current USPSTF guidelines is needed to determine the actual outcomes.

Click to read the study, published today in JAMA

RELATED REPORTS

Historical redlining associated with lower breast cancer screening across urban neighborhoods

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

Susie Wiles’ breast cancer diagnosis drives national screening surge

Relevant Reading: Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement

In-Depth [prospective cohort]: This study utilized data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, the National Lung Screening Trial (NLST), and the National Health Interview Survey (NHIS) to compare lung cancer risk-based CT screening to current USPTF screening guidelines. Current guidelines recommend annual low-dose CT scans for the identification of lung cancer in patients between the age of 55 and 80 who are current smokers or who quit within the last 15 years with at least 30 pack years of smoking history. The risk-based model, on the other hand, identifies patients at the highest estimated 5-year risk of developing lung cancer based on their specific demographic and social factors.  Results showed that screening nine million individuals between 50 and 80 years of age with CT scans for lung cancer using USPTF guidelines would prevent 46,488 (95% CI 43,924-49,053) lung cancer deaths over five years. The risk-based model was estimated to prevent 55,717 (95% CI 53,033-58,400) lung cancer deaths over five years, an 11% absolute increase (p<0.001).  Moreover, the number needed to screen was lower in the risk based model than in the USPTF model (p<0.001).

 

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: screeningsmoking
Previous Post

2 Minute Medicine Rewind May 16, 2016

Next Post

Physical activity associated with lower cancer risk

RelatedReports

Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
Reduced gestational weight gain with lifestyle intervention
Chronic Disease

A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes

September 2, 2026
High frequency of germline mutations observed in triple negative breast cancers
All Specialties

Susie Wiles’ breast cancer diagnosis drives national screening surge

September 4, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026
Next Post
Certain financial incentive programs may promote increased physical activity

Physical activity associated with lower cancer risk

Survivors of adult-onset cancers associated with increased incidence of cardiovascular disease

Chemotherapy-induced peripheral neuropathy linked to increased fall risk

New gene linked to male infertility

Weight loss for infertile-obese women does not increase vaginal birth rates

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic associations of anthropometric indices vary by clinical outcomes
  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.